In this video, Professor Dr. Christoph Correll highlights the recent innovations in the pharmacological treatment of schizophrenia. He discusses both treatments that have recently been made available in some parts of the world and those currently under development in clinical trials.

Christoph Correll image

Christoph U Correll, MD

The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA. Charité – Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.

Related content

What would be your general recommendations for clinicians treating people with schizophrenia? play_circle Video play_circle
What would be your general recommendations for clinicians treating people with schizophrenia?
09.07.2026 Schizophrenia
What is the aetiology of schizophrenia? play_circle Video play_circle
What is the aetiology of schizophrenia?

Schizophrenia remains one of psychiatry’s most complex disorders due to its multifactorial etiology, involving interacting biological, psychological, and environmental factors.

07.07.2026 Schizophrenia
grid_view Slide Deck Schizophrenia epidemiology and burden cover image
Schizophrenia – Epidemiology and burden
01.07.2026 Schizophrenia